230 related articles for article (PubMed ID: 22074484)
21. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
22. Synovial neoformations and tumours.
Szendrói M; Deodhar A
Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):363-83. PubMed ID: 10925750
[TBL] [Abstract][Full Text] [Related]
23. Cell proliferation studies in primary synovial chondromatosis.
Davis RI; Foster H; Arthur K; Trewin S; Hamilton PW; Biggart DJ
J Pathol; 1998 Jan; 184(1):18-23. PubMed ID: 9582522
[TBL] [Abstract][Full Text] [Related]
24. Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype.
Cleven AH; Zwartkruis E; Hogendoorn PC; Kroon HM; Briaire-de Bruijn I; Bovée JV
Histopathology; 2015 Oct; 67(4):483-90. PubMed ID: 25648524
[TBL] [Abstract][Full Text] [Related]
25. Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma.
Arai M; Nobusawa S; Ikota H; Takemura S; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):201-6. PubMed ID: 22323113
[TBL] [Abstract][Full Text] [Related]
26. An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait.
Odink AE; van Asperen CJ; Vandenbroucke JP; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2001 Feb; 193(2):190-2. PubMed ID: 11180165
[TBL] [Abstract][Full Text] [Related]
27. Bone tumours and tumour--like conditions--a retrospective study.
Nayar M; Chandra M; Saxena HM; Dass GC
Indian J Cancer; 1979 Jun; 16(2):18-25. PubMed ID: 546727
[No Abstract] [Full Text] [Related]
28. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
29. Alternative splicing of fibronectin transcripts in osteochondrogenic tumors.
Matsui Y; Nakata K; Araki N; Ozono K; Fujita Y; Tsumaki N; Kawabata H; Yasui N; Sekiguchi K; Yoshikawa H
Anticancer Res; 2001; 21(2A):1103-6. PubMed ID: 11396146
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
31. IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract.
Tallegas M; Miquelestorena-Standley É; Labit-Bouvier C; Badoual C; Francois A; Gomez-Brouchet A; Aubert S; Collin C; Tallet A; de Pinieux G
Hum Pathol; 2019 Feb; 84():183-191. PubMed ID: 30296521
[TBL] [Abstract][Full Text] [Related]
32. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
34. Cytologic features of primary chondroid tumors of bone in crush preparations.
Cabay RJ; Reddy V; David O; McIntire M; Cimbaluk D; Kasuganti D; Gould V; Gattuso P
Diagn Cytopathol; 2008 Oct; 36(10):758-61. PubMed ID: 18773433
[TBL] [Abstract][Full Text] [Related]
35. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
36. Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
Cancer Med; 2021 Jul; 10(13):4415-4423. PubMed ID: 34085407
[TBL] [Abstract][Full Text] [Related]
37. Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma.
Warmke LM; Cheng L; Sperling RM; Sen JD; Ulbright TM
Mod Pathol; 2022 Nov; 35(11):1636-1643. PubMed ID: 35660795
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines.
Suijker J; Oosting J; Koornneef A; Struys EA; Salomons GS; Schaap FG; Waaijer CJ; Wijers-Koster PM; Briaire-de Bruijn IH; Haazen L; Riester SM; Dudakovic A; Danen E; Cleton-Jansen AM; van Wijnen AJ; Bovée JV
Oncotarget; 2015 May; 6(14):12505-19. PubMed ID: 25895133
[TBL] [Abstract][Full Text] [Related]
39. Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes.
Jin Y; Elalaf H; Watanabe M; Tamaki S; Hineno S; Matsunaga K; Woltjen K; Kobayashi Y; Nagata S; Ikeya M; Kato T; Okamoto T; Matsuda S; Toguchida J
PLoS One; 2015; 10(7):e0131998. PubMed ID: 26161668
[TBL] [Abstract][Full Text] [Related]
40. [Cartilage tumors of the skeleton].
Jundt G; Baumhoer D
Pathologe; 2008 Nov; 29 Suppl 2():223-31. PubMed ID: 18820927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
